437 related articles for article (PubMed ID: 36874010)
1. Nanoparticle drug delivery systems for synergistic delivery of tumor therapy.
Chen D; Liu X; Lu X; Tian J
Front Pharmacol; 2023; 14():1111991. PubMed ID: 36874010
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in co-delivery nanosystems for synergistic action in cancer treatment.
Carvalho BG; Vit FF; Carvalho HF; Han SW; de la Torre LG
J Mater Chem B; 2021 Feb; 9(5):1208-1237. PubMed ID: 33393582
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Nanoparticle-Based Co-Delivery Systems for Cancer Therapy.
Al Bostami RD; Abuwatfa WH; Husseini GA
Nanomaterials (Basel); 2022 Aug; 12(15):. PubMed ID: 35957103
[TBL] [Abstract][Full Text] [Related]
4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
5. Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors.
Wang C; Guan W; Peng J; Chen Y; Xu G; Dou H
Acta Biomater; 2020 Feb; 103():247-258. PubMed ID: 31846802
[TBL] [Abstract][Full Text] [Related]
6. Inorganic nanoparticle-based advanced cancer therapies: Promising combination strategies.
Amaldoss MJN; Yang JL; Koshy P; Unnikrishnan A; Sorrell CC
Drug Discov Today; 2022 Dec; 27(12):103386. PubMed ID: 36182068
[TBL] [Abstract][Full Text] [Related]
7. Drug and gene co-delivery systems for cancer treatment.
Yang Z; Gao D; Cao Z; Zhang C; Cheng D; Liu J; Shuai X
Biomater Sci; 2015 Jul; 3(7):1035-49. PubMed ID: 26221938
[TBL] [Abstract][Full Text] [Related]
8. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
9. Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.
Zhao J; Feng SS
Nanomedicine (Lond); 2015 Jul; 10(14):2199-228. PubMed ID: 26214357
[TBL] [Abstract][Full Text] [Related]
10. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
11. Natural Compounds: Co-Delivery Strategies with Chemotherapeutic Agents or Nucleic Acids Using Lipid-Based Nanocarriers.
Teixeira PV; Fernandes E; Soares TB; Adega F; Lopes CM; Lúcio M
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111802
[TBL] [Abstract][Full Text] [Related]
12. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment.
Gao Q; Feng J; Liu W; Wen C; Wu Y; Liao Q; Zou L; Sui X; Xie T; Zhang J; Hu Y
Adv Drug Deliv Rev; 2022 Sep; 188():114445. PubMed ID: 35820601
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells.
Gaio E; Conte C; Esposito D; Miotto G; Quaglia F; Moret F; Reddi E
Mol Pharm; 2018 Oct; 15(10):4599-4611. PubMed ID: 30148955
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance.
Creixell M; Peppas NA
Nano Today; 2012 Aug; 7(4):367-379. PubMed ID: 26257819
[TBL] [Abstract][Full Text] [Related]
15. CaCO
Yang X; Sun Y; Zhang H; Liu F; Chen Q; Shen Q; Kong Z; Wei Q; Shen JW; Guo Y
Nanoscale; 2024 Apr; 16(14):6876-6899. PubMed ID: 38506154
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts.
Xu J; Zhang G; Luo X; Wang D; Zhou W; Zhang Y; Zhang W; Chen J; Meng Q; Chen E; Chen H; Song Z
Theranostics; 2021; 11(5):2475-2489. PubMed ID: 33500737
[No Abstract] [Full Text] [Related]
17. Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles.
Lin JT; Liu ZK; Zhu QL; Rong XH; Liang CL; Wang J; Ma D; Sun J; Wang GH
Colloids Surf B Biointerfaces; 2017 Jul; 155():41-50. PubMed ID: 28407530
[TBL] [Abstract][Full Text] [Related]
18. Combinations of chemo-, immuno-, and gene therapies using nanocarriers as a multifunctional drug platform.
Hopkins C; Javius-Jones K; Wang Y; Hong H; Hu Q; Hong S
Expert Opin Drug Deliv; 2022 Oct; 19(10):1337-1349. PubMed ID: 35949105
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional co-transport carriers based on cyclodextrin assembly for cancer synergistic therapy.
Yi S; Liao R; Zhao W; Huang Y; He Y
Theranostics; 2022; 12(6):2560-2579. PubMed ID: 35401819
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.
Li J; Wang Y; Zhu Y; Oupický D
J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
